Contract Manufacturing Service Agreements – Rising Manufacturing Opportunities Driven by Pharmaceutical Pipeline Expansion

Pages: 51 Published: July 30, 2020 Report Code: GDPS0032MAR

This report is a brand new publication covering contract service agreements, across a range of different services and manufacturing scales. The number of contract service agreements secured serves as a primary indicator of a CMO's performance. Contract Manufacturing Service Agreements is critical for establishing an understanding of the overall CMO industry, the range of services provided and the features of some of the largest CMOs participating in the industry.

Scope

This 51-page report gives an important expert quantitative analysis on the contract manufacturing industry. Findings are based on the industry’s most comprehensive databases of the CMO industry (GlobalData’s Databases of Contract Service Providers and Deals) this analysis is primarily driven by the Deals Database, which is continuously updated and reveals manufacturing relationships for Pharma products and the types of services offered. The 14 figures and 5 tables throughout the report illustrate major points and trends.

This report is required reading for:

• CMO executives who must have deep understanding of the novel approvals landscape to make strategic planning and investment decisions.

• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.

• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

Overview of CSAs and the levels of outsourcing associated with different services and drug type

Detailed view of CDMO performance by CSAs and an assessment of their CSAs manufacturing scale from GlobalData’s Deals database

Manufacturing Agreements for different molecule types, RoA and by sponsor company market cap have all been assessed.

Analysis of regulatory designations such as those with Orphan, Breakthrough or Fast Track designations and assessment of outsourcing

Key Players

89bio
3P Biopharmaceuticals
A+ Secure Packaging
Abcuro
Abdi Ibrahim Ilac Sanayi ve Ticaret
ABL Bio
Ablynx
Abzena
AC Immune
Academic Pharmaceuticals
Acadia Pharmaceuticals
AcelRx Pharmaceuticals
ACS Dobfar
Acumen Pharmaceuticals
Acura Pharmaceuticals
AdAlta
Adial Pharmaceuticals
Adoh
Adrenas Therapeutics
ADT Pharmaceuticals
Advent Bioservices
Advicenne
Aenova Holding
Affibody
AGC Biologics
Agilent Technologies
Aimmune Therapeutics
Ajinomoto
Akari Therapeutics
Akcea Therapeutics
Akebia Therapeutics
Akero Therapeutics
Albany Molecular Research
Albemarle
Alcami
Alchem Laboratories
Aldevron
Alector
AlfaSigma
Alkermes
Allpack Group
Almac Group
Alnylam Pharmaceuticals
Alvotech
AMAG Pharmaceuticals
Amatsigroup SAS
Amgen
Amicus Therapeutics
Ammtek
Amneal Pharmaceuticals
Amplia Therapeutics
Applied Therapeutics
Aprea Therapeutics
Aprinoia Therapeutics
Aptahem
Aptuit
Aptuit LLC
Aravive Biologics
Arbor Pharmaceuticals
Arch Biopartners
Ardena Holding
Argenx
Argonaut Manufacturing Services
Aridis Pharmaceuticals
ArTara Therapeutics
Artelo Biosciences
ASC Therapeutics
Ascletis
Aslan Pharmaceuticals
ASM - Aerosol-Service
AstraZeneca
Asymchem Laboratories
Athenex
Atossa Therapeutics
Aucta Pharmaceuticals
Aurinia Pharmaceuticals
Autolus Therapeutics
Avacta Group
AveXis
Avid Bioservices
Avion Pharmaceuticals
Axim Biotechnologies
Axovant Gene Therapies
Ayl
Aytu BioScience
AzarGen Biotechnologies
Bachem Holding
Bausch & Lomb Pharmaceuticals
Baxter International
BeiGene (Beijing)
BerGenBio
Bioasis Technologies
Biogen
Bioglan
Biohaven Pharmaceutical Holding Company
BioIent International
BioMarin Pharmaceutical
BioPharmX
Biophore India Pharmaceuticals
Biotechpharma
BJ Bioscience
Blue Water Vaccines
Blueprint Medicines
Boehringer Ingelheim Biopharmaceuticals
BriaCell Therapeutics
Bridge Therapeutics
BridgeBio Pharma
BSP Pharmaceuticals
Caladrius Biosciences
Cambrex
Camurus
Cancer Research UK; Hummingbird Bioscience Pte
Candel Therapeutics
Cantargia
Carton Service
Catalent
Catalyst Biosciences
Cell Therapies
Cell Therapy Catapult
Cellectis
CELLforCURE
Celltrion
Center Pharmaceutical Specialties
Chiasma
Chiesi Farmaceutici
Chongqing Pharmaceutical Research Institute
Cinfa Biotech
Citryll
CKD Bio
Clinical Supplies Management
Clovis Oncology
CMAB Biopharma
CNS Pharmaceuticals
Coalition for Epidemic Preparedness Innovations; Public Health Vaccines
Cobra Biologics
Cognate BioServices
Coherus BioSciences
CombiGene
Comprehensive Cell Solutions
Consort Medical
Contract Pharmaceutical Services of Australia
Contract Pharmaceuticals
CoreRx
CPC Scientific
CSBio
Cytodyn
Cytovance Biologics
Cyxone
Daiichi Sankyo
Dalton Pharma Services
Delmar Chemicals
Dermavant Sciences
Destiny Pharma
Dexcel PT Israel
DiaMedica Therapeutics
DiNAQOR
Divi's Laboratories
Dizal (Jiangsu) Pharmaceutical
Dongkook Pharmaceutical
Doppel Farmaceutici
Dova Pharmaceuticals
Dow Development Laboratories
DPT Laboratories
DURECT
Eczacibasi Monrol Nukleer Urunler Tic ve San
Eisai
EMD Serono
Emergent BioSolutions
Endo International Plc
Endocyte
Enochian Biosciences
Enzyvant Sciences
Epizyme
Esperion Therapeutics
Esteve Pharmaceuticals
Eutilex
Evonik Industries
Excella
ExCellThera
F. Hoffmann-La Roche
Fabbrica Italiana Sintetici
Fareva
Farmabios
Ferndale Pharma Group
Ferring International Center
Fidson Healthcare
Foamix Pharmaceuticals
Follicum
Fraunhofer-Gesellschaft zur Forderung der Angewandten Forschung
Freeline Therapeutics
Fresenius
Frontier Biotechnologies
Fujifilm Diosynth Biotechnologies USA
Gamida Cell
GB Sciences
Genemedicine
Genentech
Geneos Therapeutics
GeneQuantum Healthcare (Suzhou)
Genethon
Genmab
Genprex
Genscript Biotech
German Red Cross Blood Donor Service
GI Innovation
Gilead Sciences
Glatt
GlaxoSmithKline
Glycotope
Goodwin Biotechnology
GP Pharm
Grunenthal
GW Pharmaceuticals
Hansa Biopharma
Harbour BioMed
Harpoon Therapeutics
Hillstream BioPharma
Hitachi Chemical
Hookipa Pharma
Horizon Therapeutics
Hoth Therapeutics
Hovione FarmaCiencia
Hubei Haosun Pharmaceutical
Hummingbird Bioscience
iBio
Ichnos Sciences
Icon Bioscience
IDT Biologika
IGM Biosciences
I-Mab Biopharma
Immune Pharmaceuticals
ImmuneOncia Therapeutics
Immunos Therapeutics
IMPACT Therapeutics
Importfab
Indapta Therapeutics
Indivior
Inmune Bio
Insmed
Intec Pharma
Intercept Pharmaceuticals
International Isotopes
Ionic Pharmaceuticals
Iovance Biotherapeutics
iProgen Biotech
IriSys
Iroko Pharmaceuticals
Ironshore Pharmaceuticals and Development
IsoTherapeutics Group
ITG Isotope Technologies Garching
IVERIC bio
JanOne
Janssen Pharmaceuticals
Jazz Pharmaceuticals
JDP Therapeutics
Jenner Institute
Jerome Stevens Pharmaceuticals
Jubilant HollisterStier Contract Manufacturing
Just Evotec Biologics
Kamada
Kangstem Biotech
KannaLife Sciences
Karuna Therapeutics
Karyopharm Therapeutics
KBI Biopharma
King's College London
Kiniksa Pharmaceuticals
Kitov Pharma
Kyowa Kirin
L.E.A.F. Pharmaceuticals
La Jolla Pharmaceutical Company
Laboratoire Elaiapharm
Laurus Labs
Lava Therapeutics
Les Laboratoires Servier
LGC
LGM Pharma
Life Science Outsourcing
Liquidia Technologies
List Biological Laboratories
LobSor Pharmaceuticals
Lonza Group
Loxo Oncology
LTS Lohmann Therapie-Systeme
Lubrizol Life Science Health
Lyophilization Services of New England
MacroGenics
MassBiologics
MaSTherCell
Matrisys Bioscience
MaxCyte
MedPharm
Melinta Therapeutics
Merck
Meridian Medical Technologies
Mesoblast
Metacel Pharmaceuticals
MGB Biopharma
MIAS Pharma
Mikart
MilliporeSigma
Minerva Neurosciences
Mission Bio
Moleculin Biotech
Molteni Farmaceutici
Monopar Therapeutics
Mycenax Biotech
Mylan
Myovant Sciences
Nabriva Therapeutics
Nabriva Therapeutics
NBE-Therapeutics
NervGen Pharma
NGM Biopharmaceuticals
Niels Clauson- Kaas
NLS Pharmaceutics
Noramco
Nordmark Arzneimittel
Novan
Novartis
Novartis International
Novasep Holding
Novast Holdings
Novavax
Novetide
Novex Innovations
NovImmune
NuGenerex Immuno-Oncology
Oakrum Pharma
Oasmia Pharmaceutical
OishiKoseidorp
Oligomerix
Ology Bioservices
Omeros
OncoImmune
OncoResponse
Opiant Pharmaceuticals
OptiNose US
Orexigen Therapeutics
Orion
Orphelia Pharma
Otsuka Holdings
Outlook Therapeutics
Oxford BioMedica
Palatin Technologies
Patheon
Pathovax LLC
PCI Pharma Services
PEPTONIC medical
Perrigo
Pfizer
Pharmaceutics International
Pharmasol
PharmaZell
PhaseBio Pharmaceuticals
Phathom Pharmaceuticals
Phoenix Molecular Designs
Piramal Pharma Solutions
PolyPeptide Group
Portola Pharmaceuticals
Poseida Therapeutics
Prestige BioPharma
Prevail Therapeutics
Probiogen
Procos
Profectus BioSciences
Progenics Pharmaceuticals
Propak Health
Protherics UK
Provention Bio
PTC Therapeutics
Puma Biotechnology
Purdue Pharma
Q BioMed
Qpharma
QPS Holdings
Quotient Sciences
RadImmune Therapeutics
Rechon Life Science
Rechon Life Science
Recipharm
Recipharm
Recipharm (Aesica Pharmaceuticals)
RedHill Biopharma
RegenxBio
Regis Technologies
Renaissance Pharma
Rentschler Biopharma
Rentschler Fill Solutions
RespireRx Pharmaceuticals
Rexgenero
Rhythm Pharmaceuticals
Richter-Helm BioLogics
Rigel Pharmaceuticals
Rocket Pharmaceuticals
ROMEG Therapeutics
Rottendorf Pharma
Sagent Pharmaceuticals
Salix Pharmaceuticals
Samsung Bioepis
Samsung Biologics
SanBio Company
Sandoz
Sanofi
Sanquin Blood Supply Foundation
Santen Pharmaceutical
Sarepta Therapeutics
Sartorius Stedim Cellca
Satsuma Pharmaceuticals
Saudi Pharmaceutical Industries & Medical Appliances
Scilex Pharmaceuticals
ScinoPharm Taiwan
Seibersdorf Labor
Selexis
Sequential Medicine
Servier Laboratories
Sesen Bio
Shanghai ChemPartner
Shanghai Zhongxi Pharmaceutical
Sharp Packaging Services
Sheba Medical Center
Shenzhen Fapon Biopharma
Shinlin Sinseng Pharmaceutical
Shionogi
Shire
SHL Group
Siegfried Hameln
SIGA Technologies
Sonnet BioTherapeutics
Spark Therapeutics
SpectronRx
SpringWorks Therapeutics
St Renatus
Stcube
Stemline Therapeutics
Sterling Pharma Solutions
Stoke Therapeutics
Sun Pharmaceutical Industries
SutroVax
Suzhou Kintor Pharmaceuticals
Syngene International
Synthorx
TaiMed Biologics
Taimed Biologics USA
Taiwan Liposome
Takara Bio
Takeda Pharmaceutical
TCR2 Therapeutics
Tedor Pharma
Telix Pharmaceuticals
Tetraphase Pharmaceuticals
Teva Pharmaceutical Industries
TFF Pharmaceuticals
The National Institute of Allergy and Infectious Diseases
The Ritedose Corp
Therapeutics
TherapeuticsMD
Theravance Biopharma
Theravectys
Thermo Fisher Scientific (Patheon Viral Vector Services)
Titan Pharmaceuticals
Tocagen
Toyobo
Trefoil Therapeutics
Trevena
Tricida
Triphase Accelerator
UCB
Ultragenyx Pharmaceutical
UNC Lineberger Comprehensive Cancer Center
Unither Pharmaceuticals
Univar Solutions
Uquifa
UroGen Pharmaceuticals
US WorldMeds
Vaccinex
Valerius Biopharma
Valneva Sweden
Vaxart
Verastem
Vertex Pharmaceuticals
Vetter Pharma-Fertigung
VGXI
Viela Bio
ViGene Biosciences
Vir Biotechnology
Viscofan BioEngineering
Vivus
Wacker Chemie
Wavelength Enterprises
Windtree Therapeutics
WuXi AppTec
Xenikos
Xenon Pharmaceuticals
XERIS Pharmaceuticals
Xynomic Pharmaceuticals Holdings
Y-mAbs Therapeutics
Yposkesi
Yung Shin Pharmaceuticals Ind
Zambon
Zenopharm
Zhittya Genesis Medicine
Zogenix
Zosano Pharma
Zumutor Biologics

Table of Contents

1 Table of Contents

2 List of Tables

3 List of Figures

4 Executive Summary

5 Introduction

6 Contract Service Agreements Overview

7 Contract Services Offered and Manufacturing Scale

7.1 API Manufacturing Contract Service Agreements

7.2 Dose Manufacturing Contract Service Agreements

8 Contract Service Agreements by Therapy Area

9 Special Product Categories

10 Outsourcing by Sponsor Market Cap

11 CMO Performance

12 What It Means

12.1 Insights on Services Offered, Scale of Production, and CSA Relationships

12.2 Top CMO Players

12.3 Sponsor Market Cap Relationships to Outsourcing

12.4 Varying Levels of Public Disclosure

13 Notes on Methodology

14 Appendix

14.1 Appendix Tables

14.2 Bibliography

14.3 Primary Research – Key Opinion Leaders in this Report

14.4 About the Authors

14.5 Contact Us

14.6 Disclaimer

List of Tables

Table 1: Contract Service Agreements Offering More than One Manufacturing Service, 2018–2020

Table 2: Scale of Therapy Area Contract Service Agreements, 2018–2020

Table 3: Sponsor Type by Services Offered in Contract Service Agreements, 2018–2020

Table 4: Most Active Sponsors by Contract Service Agreements, 2018–2020

Table 5: Contract Service Agreements, 2018–2020

List of Figures

Figure 1: Scale of Contract Service Agreements, 2018–2020

Figure 2: Contract Service Agreements by Year, January 2018 – March 2020

Figure 3: Quantity of Services Offered Per Contract Service Agreement, 2018–2020

Figure 4: Quantity of Drugs Outsourced Per Contract Service Agreement, 2018–2020

Figure 5: Specific Services Outsourced in the Contract Service Agreements 2018–2020

Figure 6: Contract Service Agreements for Clinical-Scale API Manufacturing, 2018–2020

Figure 7: Contract Service Agreements for Commercial-Scale API Manufacturing, 2018–2020

Figure 8: Outsourced Dose Manufacturing by Molecule Type, 2018–2020

Figure 9: CSAs for Dose Manufacturing by Route of Administration, 2018–2020

Figure 10: Contract Service Agreements by Therapy Area, 2018–2020

Figure 11: Contract Service Agreements by Special Designation, 2018–2020

Figure 12: Contract Service Agreements by Sponsor Market Cap, 2018–2020

Figure 13: Most Active CMOs by Contract Service Agreements by Year, 2018–2020

Figure 14: Most Active CMOs by Contract Service Agreements by Scale, 2018–2020

$4,995

Can be used by individual purchaser only

$14,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about our multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Testimonial

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods
Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.

Pharmaceuticals
New
Net Present Value Model: (borneol + edaravone)
$500 | November 2022
Pharmaceuticals
New
Net Present Value Model: (Aspirin + Dipyridamole) ER
$500 | November 2022